Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor

Soo-Hyeon Kim1, Byung-Joon Seung1, Seung-Hee Cho1

  • 1Department of Veterinary Pathology, College of Veterinary Medicine, Konkuk University, Seoul 05025, Korea.

Insights

The PI3K/Akt/PTEN pathway is altered in canine mammary tumors. While PIK3CA H1047R mutations are present, only PTEN expression changes correlate with this specific mutation in canine mammary cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Veterinary Medicine

Background:

  • The PI3K/Akt/PTEN signaling pathway is crucial in tumorigenesis.
  • PIK3CA mutations, particularly H1047R, are common in human and canine cancers.
  • The characteristics of PIK3CA-mutated canine mammary tumors remain unclear.

Purpose of the Study:

  • To investigate the PI3K/Akt/PTEN pathway alterations in canine mammary tumors.
  • To determine the correlation between PIK3CA H1047R mutation and pathway component dysregulation.

Main Methods:

  • Analysis of 83 canine mammary samples (normal, adenoma, low-grade carcinoma, high-grade carcinoma).
  • Genomic DNA extraction, PCR amplification, and Sanger sequencing for PIK3CA mutation analysis.
  • Immunohistochemistry for PIK3CA, Akt, p-Akt, PTEN expression and RNA in situ hybridization for Akt2.

Main Results:

  • PIK3CA H1047R mutation found in 14.3% of tumor samples.
  • Dysregulation of p-Akt, Akt2, and PTEN observed in mammary tumors.
  • Only PTEN dysregulation was significantly associated with the PIK3CA H1047R mutation.

Conclusions:

  • Dysregulation of the PI3K/Akt/PTEN pathway is a feature of canine mammary tumors.
  • This pathway dysregulation is not directly linked to PIK3CA H1047R mutation, except for PTEN expression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K